Renaissance Capital logo

TRNX News

Tornier quiet period ends March 14

Tornier, which makes orthopedic implants for upper and lower extremity joints, will see its quiet period end on Monday, March 14. On February 2, the company raised $166 million by offering 8.75 million shares at $19, at the low end of the range of $19 to $21. ...read more

Tornier prices IPO at $19, at low end of the range

Tornier, which makes orthopedic implants for upper and lower extremity joints, raised $166 million by offering 8.75 million shares at $19, at the low end of the range of $19 to $21. Tornier plans to list on the NASDAQ under the symbol TRNX. BofA Merrill Lynch...read more

Warburg Pincus' Tornier sets IPO terms

Tornier, a global medical device company that supplies replacement joints to extremity surgeons, announced terms for its IPO on Tuesday. The Netherlands-based company plans to raise $175 million by offering 8.75 million shares at a price range of $19-$21. At...read more

Warburg Pincus' Tornier submits filing for $205 million IPO

Tornier, a global medical device company bought out by private equity firm Warburg Pincus that supplies replacement joints to extremity surgeons, filed on Tuesday with the SEC to raise up to $205 million in an initial public offering. The Netherlands-based...read more

Archived Headlines